Mutations in SF3B1 have been implicated as a common driver mutation in myelodysplatic syndromes (MDS), myelofibrosis and chronic myeloid leukaemia [25, 26]. Here, SF3B1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.